Announcements Trials
Browse Landscape

Status

Completed 337Recruiting 105Terminated 98Unknown 93Not yet recruiting 28Active not recruiting 26Withdrawn 24Enrolling by invitation 7Suspended 3No longer available 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 7Tumor-Agnostic 5Other hematologic neoplasm 4Sarcoma 3Head & Neck 3Endocrine 3Thoracic 2Myeloid 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Plasma cell 1NET 1Lymphoid 1Classical hematology 1

Conditions

Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Metabolic Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1Hematologic Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1Adrenoleukodystrophy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × OTHER × Classical hematology × Clear all
NCT01881334 2025-11-20

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Duke University

Available
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Adrenoleukodystrophy, Anemia, Aplastic, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Myelodysplastic Syndromes, Thalassemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡